We are live on ! Find out more
DBTX

Decibel Therapeutics, Inc. Common Stock

Delisted

DBTX was delisted on the 22nd of September, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$42.5M
TGI
2
TRV GP III
Massachusetts
$27M
BlackRock
3
BlackRock
New York
$15.7M -$2.93M -332,494 -15%
Citadel Advisors
4
Citadel Advisors
Florida
$14.9M -$40.3K -4,565 -0.3%
AI
5
Alphabet Inc
California
$14.1M
CC
6
Casdin Capital
New York
$10.1M +$221K +25,000 +2%
SB
7
Samsara BioCapital
California
$7.11M
Janus Henderson Group
8
Janus Henderson Group
$5.75M -$100K -11,389 -2%
Bessemer Group
9
Bessemer Group
New Jersey
$4.25M
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.2M +$1.66M +188,515 +103%
HMC
11
Harvard Management Company
Massachusetts
$2.83M
FCMI
12
Foresite Capital Management IV
California
$2.56M
WP
13
Woodline Partners
California
$2.41M
SCM
14
Suvretta Capital Management
New York
$2.27M
CS
15
Credit Suisse
Switzerland
$2.18M +$2.24M +253,851 New
JP Morgan Chase
16
JP Morgan Chase
New York
$1.86M -$239K -27,106 -11%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$1.84M -$1.93M -219,200 -51%
BCM
18
Bronte Capital Management
Australia
$1.37M +$1.41M +159,462 New
Morgan Stanley
19
Morgan Stanley
New York
$648K +$600K +67,984 +918%
BCM
20
Bridgeway Capital Management
Texas
$619K +$635K +72,000 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$617K -$336K -38,096 -35%
Millennium Management
22
Millennium Management
New York
$601K -$649K -73,553 -51%
ZP
23
Zimmer Partners
New York
$430K
AA
24
AlphaCentric Advisors
Puerto Rico
$387K +$318K +36,000 +400%
Neuberger Berman Group
25
Neuberger Berman Group
New York
$373K +$135K +15,350 +55%